Symbol | Exchange | Currency |
|---|
Investing.com – U.S. stocks were higher after the close on Thursday, as gains in the Oil & Gas, Basic Materials and Financials sectors led shares higher. At the close in NYSE, the...
Investing.com – U.S. stocks were lower after the close on Friday, as losses in the Technology, Consumer Services and Industrials sectors led shares lower. At the close in NYSE,...
Investing.com – U.S. stocks were higher after the close on Wednesday, as gains in the Basic Materials, Financials and Telecoms sectors led shares higher. At the close in NYSE, the...
As of late, it has definitely been a great time to be an investor in VBL Therapeutics (NASDAQ:VBLT) . The stock has moved higher by 5.5% in the past month, while it is also above...
Investors in Vascular Biogenics Ltd. (NASDAQ:VBLT) need to pay close attention to the stock based on moves in the options market lately. That is because the Jun 15, 2018 $10.00...
Similar to wise buying decisions, exiting certain underperformers at the right time helps maximize portfolio returns. Selling off losers can be difficult, but if both the share...
Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antibody-based technology that enables specifically inhibit monocyte migration for immune-inflammatory applications. The company’s lead product candidate is VB-111, a gene-based biologic that is in Phase III clinical trials for the recurrent platinum-resistant ovarian cancer; and Phase II clinical trials treatment of recurrent glioblastoma and colorectal cancer, as well as has completed Phase II clinical trial for the treatment of thyroid cancer. It is also developing VB-601 for various inflammatory indications, and VB-611 for various solid tumors. The company was formerly known as Medicard Ltd. and changed its name to Vascular Biogenics Ltd. in January 2003. Vascular Biogenics Ltd. was incorporated in 2000 and is headquartered in Modi’in, Israel.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Buy | Strong Buy | Sell |
| Technical Indicators | Strong Sell | Neutral | Strong Buy | Strong Buy | Strong Sell |
| Summary | Neutral | Buy | Strong Buy | Strong Buy | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 94.48 | 95.09 | 86.73 | +12.17 | +14.79% | 45.63M | NYSE | |||
| 550.66 | 554.57 | 527.72 | +19.03 | +3.58% | 3.95M | NASDAQ | |||
| 236.70 | 239.43 | 234.52 | +4.09 | +1.76% | 947.58K | NYSE | |||
| 41.93 | 42.17 | 38.82 | +3.62 | +9.45% | 11.22M | NASDAQ | |||
| 46.53 | 46.68 | 45.05 | +0.61 | +1.33% | 61.60K | OTC Markets | |||
| 170.11 | 171.09 | 168.96 | +1.14 | +0.67% | 5.18M | NASDAQ | |||
| 69.53 | 70.85 | 68.88 | -0.77 | -1.10% | 5.44M | NYSE | |||
| 1.95 | 1.95 | 1.70 | +0.280 | +16.77% | 43.63K | NASDAQ | |||
| 58.11 | 58.27 | 55.58 | +2.33 | +4.18% | 4.06M | NYSE | |||
| 57.94 | 58.10 | 57.31 | +0.48 | +0.84% | 91.53K | NYSE | |||
| 1.07 | 2.01 | 1.05 | -2.310 | -68.34% | 18.48M | NASDAQ | |||
| 21.81 | 21.98 | 21.40 | +0.42 | +1.96% | 1.06M | NYSE | |||
| 4.75 | 4.95 | 4.688 | +0.045 | +0.96% | 10.79K | NASDAQ | |||
| 6.68 | 6.95 | 6.37 | +0.21 | +3.25% | 7.00M | NYSE | |||
| 0.88 | 1.12 | 0.76 | +0.21 | +31.76% | 2.26M | NASDAQ |